Yuanqiang Li

机构：Åbo Akademi University, China Three Gorges University, Zhejiang Cancer Hospital, Second Hospital of Yichang, Yichang Central People's Hospital · ORCID：0000-0002-8262-2983

发表论文 17 篇 · 总被引 244 次 · h-index 8

代表论文

• Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy (2024 · Nature Communications · 被引 73)
• Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived (2024 · Molecular Medicine · 被引 36)
• Long Non-Coding RNA NORAD Inhibits Breast Cancer Cell Proliferation and Metastasis by Regulating miR-155-5p/SOCS1 Axis (2021 · Journal of Breast Cancer · 被引 25)
• miR-149* Suppresses Liver Cancer Progression by Down-Regulating Tumor Necrosis Factor Receptor 1–Associated Death Domain Protein Expression (2019 · American Journal Of Pathology · 被引 22)
• Role of G-protein coupled receptors in cardiovascular diseases (2023 · Frontiers in Cardiovascular Medicine · 被引 21)
• Deficiency of miRNA-149-3p shaped gut microbiota and enhanced dextran sulfate sodium-induced colitis (2022 · Molecular Therapy — Nucleic Acids · 被引 17)